IDENTIFICATION OF NOVEL VARIANTS IN THE HEPATOCYTE NUCLEAR FACTOR 1 ALPHA GENE IN SOUTH INDIAN PATIENTS WITH MATURITY ONSET DIABETES OF YOUNG
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
IDENTIFICATION OF NOVEL VARIANTS IN THE HEPATOCYTE NUCLEAR FACTOR 1 ALPHA GENE IN SOUTH INDIAN PATIENTS WITH MATURITY ONSET DIABETES OF YOUNG. / Radha, V; Ek, J; Anuradha, S; Hansen, T; Pedersen, Oluf; Mohan, V.
In: Journal of Clinical Endocrinology and Metabolism, Vol. 6, 2009, p. 1959-65.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - IDENTIFICATION OF NOVEL VARIANTS IN THE HEPATOCYTE NUCLEAR FACTOR 1 ALPHA GENE IN SOUTH INDIAN PATIENTS WITH MATURITY ONSET DIABETES OF YOUNG
AU - Radha, V
AU - Ek, J
AU - Anuradha, S
AU - Hansen, T
AU - Pedersen, Oluf
AU - Mohan, V
PY - 2009
Y1 - 2009
N2 - Context: Mutations in the HNF 1A gene are the commonest cause of maturity-onset diabetes of the young (MODY) in most populations. India currently has the largest number of people with diabetes in the world and onset of type 2 diabetes occurs at a younger age with possible overlap with MODY. There is very little data on MODY mutations from India. Objective: The objective was to screen coding and promoter regions of HNF1A gene for mutations in unrelated South Indian subjects in whom a clinical diagnosis of MODY was made. Design: An observational cross-sectional study. Setting: A Diabetes Specialities Centre in Chennai, in southern India. Patients: Ninty-six unrelated south Indian subjects in whom clinical diagnosis of MODY was made were included in the study. The control population comprised of 57 unrelated non-diabetic subjects selected from the Chennai Urban Rural Epidemiology Study (CURES), a study conducted on a representative population (aged >/= 20 years) of Chennai. Results: We identified 9 novel variants comprising 7 mutations(one novel mutation -538G-->C at promoter region and six novel coding region mutations) and 2 polymorphisms in the HNF1A gene. Functional studies revealed reduced transcriptional activity of the HNF1A promoter for two of promoter variants. We also observed co-segregation with diabetes of the Arg263His coding region mutation in 8 members of one MODY family while it was absent in non-diabetic subjects of this family. Conclusion: This study suggests that mutations in HNF1Agene comprise about 9% of clinically diagnosed MODY subjects in S. India and a novel Arg263His mutation cosegregates with MODY in one family.
AB - Context: Mutations in the HNF 1A gene are the commonest cause of maturity-onset diabetes of the young (MODY) in most populations. India currently has the largest number of people with diabetes in the world and onset of type 2 diabetes occurs at a younger age with possible overlap with MODY. There is very little data on MODY mutations from India. Objective: The objective was to screen coding and promoter regions of HNF1A gene for mutations in unrelated South Indian subjects in whom a clinical diagnosis of MODY was made. Design: An observational cross-sectional study. Setting: A Diabetes Specialities Centre in Chennai, in southern India. Patients: Ninty-six unrelated south Indian subjects in whom clinical diagnosis of MODY was made were included in the study. The control population comprised of 57 unrelated non-diabetic subjects selected from the Chennai Urban Rural Epidemiology Study (CURES), a study conducted on a representative population (aged >/= 20 years) of Chennai. Results: We identified 9 novel variants comprising 7 mutations(one novel mutation -538G-->C at promoter region and six novel coding region mutations) and 2 polymorphisms in the HNF1A gene. Functional studies revealed reduced transcriptional activity of the HNF1A promoter for two of promoter variants. We also observed co-segregation with diabetes of the Arg263His coding region mutation in 8 members of one MODY family while it was absent in non-diabetic subjects of this family. Conclusion: This study suggests that mutations in HNF1Agene comprise about 9% of clinically diagnosed MODY subjects in S. India and a novel Arg263His mutation cosegregates with MODY in one family.
U2 - 10.1210/jc.2008-2371
DO - 10.1210/jc.2008-2371
M3 - Journal article
C2 - 19336507
VL - 6
SP - 1959
EP - 1965
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
ER -
ID: 11953632